| 000 | 01273 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513031858.0 | ||
| 264 | 0 | _c19950922 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a0090-4295 | ||
| 024 | 7 |
_a10.1016/s0090-4295(99)80247-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOesterling, J E | |
| 245 | 0 | 0 |
_aUsing prostate-specific antigen to eliminate unnecessary diagnostic tests: significant worldwide economic implications. _h[electronic resource] |
| 260 |
_bUrology _cSep 1995 |
||
| 300 |
_a26-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBiopsy _xeconomics |
| 650 | 0 | 4 |
_aBone and Bones _xdiagnostic imaging |
| 650 | 0 | 4 | _aCost Control |
| 650 | 0 | 4 |
_aDiagnostic Tests, Routine _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Node Excision _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xeconomics |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aRadionuclide Imaging _xeconomics |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 773 | 0 |
_tUrology _gvol. 46 _gno. 3 Suppl A _gp. 26-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(99)80247-7 _zAvailable from publisher's website |
| 999 |
_c7543971 _d7543971 |
||